IP Library Granted Patent US 11,253,479
Granted Patent B2
US 11,253,479 · App. 15/795,873 · Granted Feb 22, 2022

Hydrobromide salt of an anti-HIV compound

Inventor: Daniel Joseph Christiaan Thoné (Beerse, BE)
Assignee: Janssen Sciences Ireland Unlimited Company
A61K9/1635A61K9/1641A61K9/1652A61K9/145
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,253,479
App. No.
15/795,873
Granted
Feb 22, 2022
Kind
B2
Abstract

Solid dispersions and dosage forms comprising the hydrobromide salt of a diarylpyrimidine derivative, useful as an anti-HIV agent.

Claims (16)

1. A solid dispersion comprising a compound of formula (I):

in a water-soluble polymer selected from hydroxypropylmethyl cellulose 2910 5 mPa·s and vitamin E TGPS, wherein the weight:weight ratio of the water-soluble polymer to the compound of formula (I) is about 10:1 or about 9:1.

2. The solid dispersion according to claim 1 , wherein the weight:weight ratio of the water-soluble polymer to the compound of formula (I) is about 9:1.

3. A dosage form comprising the solid dispersion of claim 1 .

4. The dosage form of claim 3 wherein the dosage form is selected from a tablet and a capsule.

5. The solid dispersion according to claim 1 obtainable by spray-drying.

6. The solid dispersion according to claim 5 , further containing microcrystalline cellulose.

7. The solid dispersion according to claim 1 , wherein the water-soluble polymer is hydroxypropylmethyl cellulose 2910 5 mPa·s.

8. The solid dispersion according to claim 1 , wherein the water-soluble polymer is vitamin E TGPS.

9. The solid dispersion according to claim 7 , wherein the weight:weight ratio of the water-soluble polymer to the compound of formula (I) is about 9:1.

10. The solid dispersion according to claim 8 , wherein the weight:weight ratio of the water-soluble polymer to the compound of formula (I) is about 9:1.

11. The dosage form of claim 3 , wherein the water-soluble polymer is hydroxypropylmethyl cellulose 2910 5 mPa·s.

12. The dosage form of claim 3 , wherein the water-soluble polymer is vitamin E TGPS.

13. The dosage form of claim 3 , wherein the weight:weight ratio of the water-soluble polymer to the compound of formula (I) is about 9:1.

14. The dosage form of claim 11 , wherein the weight:weight ratio of the water-soluble polymer to the compound of formula (I) is about 9:1.

15. The dosage form of claim 12 , wherein the weight:weight ratio of the water-soluble polymer to the compound of formula (I) is about 9:1.

Assignments (2)
CHANGE OF NAME Recorded Jul 27, 2022
From: JANSSEN SCIENCES IRELAND UC
To: JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
Reel/Frame 060989/0661 →
CHANGE OF NAME Recorded Dec 2, 2021
From: JANSSEN SCIENCES IRELAND UC
To: JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
Reel/Frame 058295/0556 →
Priority Claims (1)
EP 06125547 · Dec 6, 2006 · regional
Continuity (2)
Continuation 12517665
Related Publication 20180049986A1 · Feb 22, 2018